Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
How does external reference pricing work in developing countries: evidence from Iran.
Fatemeh Babaie1, Mohammad Hossein Motevalli1, Gholamhossein Mehralian2
1Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
External reference pricing (ERP) is a widely used medicine pricing policy. While effective in the short term, ERP alone is not perfect for ensuring fair pharmaceutical prices, suggesting complementary methods improve patient access.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Drug Pricing
Background:
- Governments utilize diverse pricing strategies to ensure medicine accessibility, availability, and affordability.
- External reference pricing (ERP) is a common, easily implemented policy across many countries.
- ERP's path dependency presents both advantages and disadvantages, complicating impact assessment.
Purpose of the Study:
- To evaluate the performance of external reference pricing (ERP) as a drug pricing tool in Iran.
- To analyze the impact of different reference country selections on ERP outcomes.
- To compare medicine prices in Iran with those in socioeconomically comparable reference countries.
Main Methods:
- A cross-sectional descriptive study was conducted.
- Iran's official reference country basket was supplemented with countries selected for socioeconomic comparability and data access.
- An empirical analysis compared prices of selected medicines in Iran against these reference countries.
Main Results:
- Prices of 57 medicines (69.2% of Iran's imported pharma market value) were analyzed.
- 49.1% of medicines were priced higher in at least one reference country.
- 21% of products showed higher average prices in Iran compared to the average in reference countries.
Conclusions:
- External reference pricing (ERP) offers a viable short-term solution for pharmaceutical pricing challenges.
- ERP is not a perfect standalone pricing tool; its effectiveness is acceptable but can be enhanced.
- Integrating ERP with other methods, like value-based pricing, can improve patient access to medicines in Iran.
Related Concept Videos
Bioequivalence: Overview
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Regression Toward the Mean
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...

